Stay updated on Amivantamab in Esophagogastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Amivantamab in Esophagogastric Cancer Clinical Trial page.

Latest updates to the Amivantamab in Esophagogastric Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page’s footer indicates an update to the ClinicalTrials.gov interface/version (revision v3.5.3 instead of v3.5.2). This reflects a version change of the site rather than an update to the trial details.SummaryDifference0.1%

- Check16 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check45 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the site metadata.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check74 days agoChange DetectedNew update entries for 2026-02-12 and 2026-02-17 were added and older 2025 entries removed, updating the study record’s last-update information and QC status.SummaryDifference0.2%

- Check81 days agoChange DetectedThe page now displays Revision: v3.4.2, and previous notices about government funding lapses and the prior v3.4.1 update have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Amivantamab in Esophagogastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab in Esophagogastric Cancer Clinical Trial page.